Michael Friedman
Board Member
Galera Therapeutics, Inc. (GRTXD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Friedman
Michael Friedman is recorded as Board Member at Galera Therapeutics, Inc. (GRTXD). Galera Therapeutics, Inc. reported in an 8-K filed August 4, 2026 that Michael Friedman resigned as Board, effective August 3, 2026. Galera Therapeutics, Inc. reported in an 8-K filed December 31, 2024 that Michael Friedman was appointed Class I director, effective December 30, 2024.
“In accordance with the Merger Agreement, immediately prior to the closing of the Mergers, J. Mel. Sorensen, Michael Friedman, Nancy Chang, Lawrence Alleva and Kevin Lokay resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with the Company relating to its operations, policies or practices.”
“On December 30, 2024, effective immediately after the First Effective Time, Nancy Chang, Ph.D. and Michael Friedman were appointed as members of the Board as Class I directors (such appointees, collectively the "Director Appointees").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-12-30–present
-
2024-12-30–2026-08-03
-
2024-01-01–2026-08-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Galera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Joel Sussman Chief Accounting Officer
- Nancy Chang, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.